BioNTech SE (BNTX) Misses Q2 EPS by 18c

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of (EUR2.22), EUR0.18 worse than the analyst estimate of (EUR2.04). Revenue for the quarter came in at EUR105.6 million versus the consensus estimate of EUR162.59 million.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Bessent defends yen support, cites US borrowing cost risks
• Popular stocks with increasing option volume: MU SPCX MSTR INTC MRVL PLTR SOFI AMD SMCI CRM HOOD